# Lanreotide in endothelial corneal inflammation.

> PubMed lists PMID 41071230 in Hormones (Athens, Greece) as Letter, with publication-date metadata of 2025-10-10 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41071230-lanreotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-03-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41071230-lanreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41071230-lanreotide-v1.json
- Content SHA-256: `88dddbfa40c80f3a543a974032a5ffea80b414e67cdea03507474d691347d69f`

## Claims and source pins

### Headline

Lanreotide in endothelial corneal inflammation. ([`pubmed-observation-pmid-41071230-2026-03-25-a4ce3d1a2dbb`](#source-pubmed-observation-pmid-41071230-2026-03-25-a4ce3d1a2dbb))

### Summary

PubMed lists PMID 41071230 in Hormones (Athens, Greece) as Letter, with publication-date metadata of 2025-10-10 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41071230-2026-03-25-a4ce3d1a2dbb`](#source-pubmed-observation-pmid-41071230-2026-03-25-a4ce3d1a2dbb))

### Paragraph 1

PubMed lists PMID 41071230 in Hormones (Athens, Greece) as Letter, with publication-date metadata of 2025-10-10 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41071230-2026-03-25-a4ce3d1a2dbb`](#source-pubmed-observation-pmid-41071230-2026-03-25-a4ce3d1a2dbb))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41071230-2026-03-25-a4ce3d1a2dbb`](#source-pubmed-observation-pmid-41071230-2026-03-25-a4ce3d1a2dbb))

## Sources

<a id="source-pubmed-observation-pmid-41071230-2026-03-25-a4ce3d1a2dbb"></a>
- **Lanreotide in endothelial corneal inflammation. · retained source version 1:2026-03-25:current:a4ce3d1a2dbbb3d55f7922623629a063ca8894c59c34cdb0e9d9cc10d4ede6bd** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41071230/) (`pubmed-observation-pmid-41071230-2026-03-25-a4ce3d1a2dbb`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Lanreotide in endothelial corneal inflammation." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41071230-lanreotide-v1.json SHA-256: 88dddbfa40c80f3a543a974032a5ffea80b414e67cdea03507474d691347d69f.